MLPA® - MRC Holland Kits

Please note before download:

  • Mix descriptions are only free of charge for customers with maintenance contract.
  • Don't hesitate to contact us, if there are any mix descriptions missing on this website.
  • To set up a new mix descriptions for you, still available at MRC Hollands website, please provide us the name of the mix (e.g. P002-D1), the version of the mix (e.g. Vs.02) and the date of its release.

  • To set up a new mix descriptions for you, not available at MRC Hollands website any more, please provide us the corresponding document by email or fax (+49-7822-440150-20).

Download

  • log into your SEQUENCE Pilot installation
  • go to category MLPA®
  • go to operation Mixes [master file]
  • press button [Import] and select the downloaded mme-file
  • if the corresponding mix already exists in your SEQUENE_PILOT installation you will be asked "Do you want to save the mix with a new name / lot?"; please press button [Yes] and complete the fields in the following dialogue; press button [OK] to save your entries
  • if the mix doesn't exist yet just press button [OK] in the following dialogue
MIX
VERSION
DATE
REGION
APPLICATION
DOWNLOAD
MIX
P480-A1
VERSION
Vs. A1-01
DATE
19-09-2018
REGION
4p16.3
APPLICATION
Wolf-Hirschhorn syndrome; Achondroplasia
MIX
P481-A1
VERSION
Vs. A1-01
DATE
09-12-2020
REGION
PRKAR1A (17q24.2), ARMC5 (16p11.2)
APPLICATION
Carney complex, acrodysostosis, pituitary adenoma, adrenal hyperplasia, adrenocortical disease and tumours
MIX
P482-A1
VERSION
Vs. A1-01
DATE
10-12-2019
REGION
DICER1, 14q32.13
APPLICATION
DICER1 syndrome, Goiter with or without Sertoli-Leydig cell tumors, Pleuropulmonary blastoma
MIX
P482-A1
VERSION
Vs. A1-03
DATE
17-10-2023
REGION
DICER1, 14q32.13
APPLICATION
DICER1 syndrome, Goiter with or without Sertoli-Leydig cell tumors, Pleuropulmonary blastoma
MIX
P484-A1
VERSION
Vs. A1-01
DATE
24-10-2018
REGION
ALPL 1p36
APPLICATION
Hypophosphatasia (HPP)
MIX
P484-A1
VERSION
Vs. A1-02
DATE
06-08-2020
REGION
ALPL 1p36.12
APPLICATION
Hypophosphatasia (HPP)
MIX
P488-B1
VERSION
Vs. B1-01
DATE
31-01-2020
REGION
RS1 Xp22.13
APPLICATION
X-linked retinoschisis (XLRS)
MIX
P489-A1
VERSION
Vs. A1-01
DATE
05-06-2020
REGION
BARD1 2q35
APPLICATION
Hereditary breast, Ovarian cancer, Neuroblastoma
MIX
P489-A1
VERSION
Vs. A1-02
DATE
19-01-2021
REGION
BARD1 2q35
APPLICATION
Breast and ovarian cancer, hereditary
MIX
P490-B1
VERSION
Vs. B1-01
DATE
29-04-2020
REGION
22q11.1
APPLICATION
Adenosine deaminase 2
MIX
P492-A1
VERSION
Vs. A1-01
DATE
30-08-2021
REGION
POLD1 19q13.33; POLE 12q24.33
APPLICATION
Colorectal cancer, susceptibility
MIX
P492-A1
VERSION
Vs. A1-03
DATE
16-09-2021
REGION
POLD1 19q13.33; POLE 12q24.33
APPLICATION
Colorectal cancer, susceptibility
MIX
P493-A1
VERSION
Vs. A1-01
DATE
15-02-2022
REGION
SMCHD1 18p11.32
APPLICATION
FSHD2
MIX
P494-A1
VERSION
Vs. A1-01
DATE
28-07-2021
REGION
NBN 8q21.3
APPLICATION
Nijmegen Breakage Syndrome; Breast cancer
MIX
P495-A1
VERSION
Vs. A1-01
DATE
25-10-2022
REGION
CYP11A1 15q24.1; CYP11B1 8q24.3; CYP11B2 8q24.3
APPLICATION
Adrenal insufficiency; CAH, pseudohypo- and pseudohyperaldosteronism
MIX
P496-A1
VERSION
Vs. A1-02
DATE
30-11-2023
REGION
KMT2A, chr. 5, 7, 11 and 17
APPLICATION
Acute Myeloid Leukemia (AML) and other hematological malignancies
MIX
P497-A1
VERSION
Vs. A1-01
DATE
11-12-2023
REGION
Xq28
APPLICATION
cone photoreceptor disorders